LIXT logo

LIXT Accounts Payable

Annual Accounts Payable

$120.50 K
-$63.30 K-34.44%

December 31, 2023


Summary


Performance

LIXT Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLIXTbalance sheetmetrics:

Quarterly Accounts Payable

N/A

September 30, 2024


Summary


Performance

LIXT Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLIXTbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

LIXT Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.4%-
3 y3 years-36.7%-
5 y5 years--

LIXT Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.4%at low
5 y5-year-36.7%at low
alltimeall time-61.4%+725.3%

Lixte Biotechnology Holdings Accounts Payable History

DateAnnualQuarterly
Dec 2023
$120.50 K(-34.4%)
$120.50 K(-34.4%)
Dec 2022
$183.80 K(-3.4%)
$183.80 K(-20.8%)
Sep 2021
-
$232.00 K(+42.9%)
Jun 2021
-
$162.40 K(+9.1%)
Mar 2021
-
$148.90 K(-21.8%)
Dec 2020
$190.30 K(+32.6%)
$190.30 K(+64.8%)
Sep 2020
-
$115.50 K(-39.2%)
Jun 2020
-
$189.90 K(+18.0%)
Mar 2020
-
$160.90 K(+12.1%)
Dec 2019
$143.50 K(-54.0%)
$143.50 K(-47.5%)
Sep 2019
-
$273.50 K(+48.7%)
Jun 2019
-
$183.90 K(-12.7%)
Mar 2019
-
$210.70 K(-46.9%)
Sep 2018
-
$396.60 K(+43.7%)
Jun 2018
-
$275.90 K(+46.4%)
Mar 2018
-
$188.50 K(-39.6%)
Dec 2017
$312.00 K(+95.5%)
$312.00 K(+91.2%)
Sep 2017
-
$163.20 K(-18.8%)
Jun 2017
-
$201.10 K(-5.2%)
Mar 2017
-
$212.20 K(+33.0%)
Dec 2016
$159.60 K(+0.3%)
$159.60 K(+42.4%)
Sep 2016
-
$112.10 K(+44.6%)
Jun 2016
-
$77.50 K(-7.1%)
Mar 2016
-
$83.40 K(-47.6%)
Dec 2015
$159.10 K(+29.9%)
$159.10 K(+31.3%)
Sep 2015
-
$121.20 K(+55.4%)
Jun 2015
-
$78.00 K(-29.1%)
Mar 2015
-
$110.00 K(-10.2%)
Dec 2014
$122.50 K
$122.50 K(-6.1%)
DateAnnualQuarterly
Sep 2014
-
$130.50 K(+17.5%)
Jun 2014
-
$111.10 K(+37.2%)
Mar 2014
-
$81.00 K(-24.9%)
Dec 2013
$107.80 K(+34.1%)
$107.80 K(+66.9%)
Sep 2013
-
$64.60 K(-2.1%)
Jun 2013
-
$66.00 K(-9.5%)
Mar 2013
-
$72.90 K(-9.3%)
Dec 2012
$80.40 K(-26.4%)
$80.40 K(-42.9%)
Sep 2012
-
$140.70 K(-13.7%)
Jun 2012
-
$163.10 K(+1.2%)
Mar 2012
-
$161.20 K(+47.5%)
Dec 2011
$109.30 K(+6.8%)
$109.30 K(-29.5%)
Sep 2011
-
$155.10 K(+0.2%)
Jun 2011
-
$154.80 K(+51.3%)
Dec 2010
$102.30 K(+38.8%)
$102.30 K(+10.4%)
Sep 2009
-
$92.70 K(0.0%)
Mar 2009
-
$92.70 K(-8.2%)
Sep 2008
-
$101.00 K(+109.5%)
Jun 2008
-
$48.20 K(-26.5%)
Mar 2008
-
$65.60 K(-11.0%)
Dec 2007
$73.70 K(+131.8%)
$73.70 K(+94.5%)
Sep 2007
-
$37.90 K(+226.7%)
Jun 2007
-
$11.60 K(-83.2%)
Mar 2007
-
$68.90 K(+116.7%)
Dec 2006
$31.80 K(+117.8%)
$31.80 K(+84.9%)
Sep 2006
-
$17.20 K(-43.8%)
Jun 2006
-
$30.60 K(+7550.0%)
Mar 2006
-
$400.00
Dec 2005
$14.60 K
-

FAQ

  • What is Lixte Biotechnology Holdings annual accounts payable?
  • What is the all time high annual accounts payable for Lixte Biotechnology Holdings?
  • What is Lixte Biotechnology Holdings annual accounts payable year-on-year change?
  • What is the all time high quarterly accounts payable for Lixte Biotechnology Holdings?

What is Lixte Biotechnology Holdings annual accounts payable?

The current annual accounts payable of LIXT is $120.50 K

What is the all time high annual accounts payable for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high annual accounts payable is $312.00 K

What is Lixte Biotechnology Holdings annual accounts payable year-on-year change?

Over the past year, LIXT annual accounts payable has changed by -$63.30 K (-34.44%)

What is the all time high quarterly accounts payable for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high quarterly accounts payable is $396.60 K